Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 82
Central Nervous System Drugs 67
Endocrine and Metabolic Disorders Drugs 50
Infusions and Injectables 33
Musculoskeletal Disorders Drugs 27
Surgical Procedures 21
Drug Discovery 20
Pharmaceuticals 20
Biopharmaceuticals 15
Prostate Cancer Drugs 13
Drug Delivery 13
Liver Cancer Drugs 10
Women's Health 10
Clinical Trials 10
Dermatology 10
Oncology 10
Neurology 9
Pancreatic Cancer Drugs 9
Medical Devices 8
Thyroid Cancer Drugs 8
Biotechnology 7
Lung Cancer Drugs 7
Healthcare Services 6
Breast Cancer Drugs 6
Genomics 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Company Reports 5
Immune Disorders Drugs 5
Kidney Cancer Drugs 5
Dermatological Drugs 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Enzymes 4
Sexual and Reproductive Health Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Ovarian Cancer Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Over the Counter (OTC) Drugs 3
Urological Disorders Drugs 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Needles and Syringes 2
Hematology 2
Surgical Devices 2
Hematological Drugs 2
Biosimilars and Biosuperiors 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Endocrinology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

452 Results (Page 20 of 23)
- Relevance
  Sort by

Hyperlipidemia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3983EUR$4,490USD£3,477GBP

Epigenetic Therapeutics: Global Markets

 Report
June 2023
155 Pages
Global

From

€4125EUR$4,650USD£3,601GBP

Facial Injectables Market Size, Share, Trends and Forecast by Product Type, Application Type, Application, End User, and Region, 2025-2033

 Report
August 2025
136 Pages
Global

From

€2262EUR$2,549USD£1,974GBP

€2661EUR$2,999USD£2,322GBP

Non-surgical Cosmetic Procedures Market 2025-2029

 Report
May 2025
231 Pages
Global

From

€2218EUR$2,500USD£1,936GBP

Endometriosis Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3983EUR$4,490USD£3,477GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a Landscape Analysis of Technologies, Targets, Business and Financing from An Industry Perspective

 Report
November 2022
418 Pages
Global

From

€2350EUR$2,838USD£2,123GBP

Orphan Drugs Market 2024-2028

 Report
August 2024
180 Pages
Global

From

€2218EUR$2,500USD£1,936GBP

Aesthetic Injectables Market - Global Forecast 2025-2032

 Report
October 2025
185 Pages
Global

From

€3145EUR$3,545USD£2,745GBP

€3495EUR$3,939USD£3,050GBP

Medical Beauty Regeneration Injection Materials Market - Global Forecast 2025-2030

 Report
August 2025
198 Pages
Global

From

€3145EUR$3,545USD£2,745GBP

€3495EUR$3,939USD£3,050GBP

Cosmetic Injectable Service Market - Global Forecast 2025-2030

 Report
August 2025
193 Pages
Global

From

€3145EUR$3,545USD£2,745GBP

€3495EUR$3,939USD£3,050GBP

Prostate Cancer Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
August 2023
124 Pages
Global

From

€3500EUR$4,226USD£3,162GBP

Facial Injectable Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
June 2025
183 Pages
Global

From

€3992EUR$4,500USD£3,485GBP

Polycystic Kidney Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
98 Pages
Global

From

€3500EUR$4,226USD£3,162GBP

Middle East & Africa Neurotoxins Market Forecast to 2028 -Regional Analysis

 Report
July 2023
105 Pages
Africa, Middle East

From

€3061EUR$3,450USD£2,672GBP

Europe Neurotoxins Market Forecast to 2028 -Regional Analysis

 Report
July 2023
119 Pages
Europe

From

€3061EUR$3,450USD£2,672GBP

Radiotheranostics Market by Radioisotope, Application, End-user and Region: Competition Forecast and Opportunities to 2027

 Report
October 2022
118 Pages
Global

From

€3992EUR$4,500USD£3,485GBP

Glabellar Lines - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€887EUR$1,000USD£774GBP

€1109EUR$1,250USD£968GBP

South America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and End User

 Report
August 2023
93 Pages

From

€3061EUR$3,450USD£2,672GBP

North America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and End User

 Report
August 2023
99 Pages
North America

From

€3061EUR$3,450USD£2,672GBP

Asia Pacific Neurotoxins Market Forecast to 2028 -Regional Analysis

 Report
June 2023
110 Pages
Asia Pacific

From

€3061EUR$3,450USD£2,672GBP

452 Results (Page 20 of 23)
- 1
- 18
- 19
- 20
- 21
- 22

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.